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Half-sandwich rhodium(III) and ruthenium(II) complexes bearing a new redox-active ferrocenyl NHC-
thioether ligand have been prepared. The synthesis of ferrocenyl thioether-imidazolium salts 3a and 3b 
was carried out via intermediate 2 using an improved procedure. Rhodium(III) complex 4 and 
ruthenium(II) complex 5 were obtained in good yields and were fully characterised by NMR 10 
spectroscopy, X-ray diffraction analysis and electrochemistry. Complex 4 shows a complex ABCD 
system by 1H NMR, which denotes conformational rigidity due to the presence of several bulky groups. 
Electrochemical analysis by cyclic voltammetry reveals reversible redox behaviour about the iron centre 
in 4 and 5, and indicates electronic communication between iron and rhodium or ruthenium. 
Introduction 15 
N-Heterocyclic carbenes (NHCs) have become widely used 
ligands in many areas from transition metal catalysis,1 
organocatalysis,2 to biochemistry and medicine.3 They are 
generally described as organophosphine analogues, although their 
-donor character is more pronounced. Unlike phosphines, they 20 
generally lead to air-stable, robust complexes which do not easily 
undergo ligand dissociation. However, the M-C bond stability 
could be detrimental to the catalytic activity. Functionalized N-
heterocyclic carbene ligands combine the robust nature of the 
resulting metal-NHC bond with the flexibility of the secondary 25 
donor function (hemilability, stereoelectronic control on the 
active site) and have been successfully used in many catalytic 
reactions.4-6 However, any alteration of steric or electronic 
properties of a ligand implies structural modifications and thus 
more synthetic work. 30 
 Fine tuning of the electronic properties can also be achieved by 
introduction of redox-active moieties in the ligands.7 This has 
been demonstrated in the field of small molecule sensing 8,9 and 
in catalysis.10 In the latter domain, transition metal complexes 
containing either substitutionally inert 11 or hemilabile 12 redox-35 
active ligands have shown charge-dependent behaviour. 
 Our group has a strong interest in the chemistry and catalytic 
activity of functionalised N-heterocyclic carbene complexes. We 
have shown that NHCs bearing thioether or phosphine donors 
give very efficient and robust catalysts.13,14 The work reported 40 
here describes the preparation of redox-active NHC-thioether 
ligands incorporating the ubiquitous ferrocene group and the 
study of their coordination chemistry and electrochemical 
behaviour. 
Results and discussion 45 
Synthesis 
 
Scheme 1 Synthesis of imidazolium salts 3a and 3b. 
The synthesis of the imidazolium salt 3b, i.e. the NHC-thioether 
precursor, was achieved in three steps from bromoferrocene 1. 50 
Although the preparation of intermediate 2 and its 1,1’-
disubstituted analogue have been described by Mirkin et al.,15,16 
we decided to follow a different synthetic route. Mirkin’s 
reported procedures involved the monolithiation of ferrocene and 
afforded the products in very low yields, by reaction with S8 and 55 
tosylate TsOCH2CH2Cl (compound 2, 15% yield),
15 or with 
disulfide (ClCH2CH2S)2 (1,1’-disubstituted analogue, 13% 
yield).16 We decided to start from bromoferrocene, which could 
be selectively and efficiently transformed into lithioferrocene. 
The reaction of the latter with bis(2-chloroethyl) disulfide was 60 
then carried out at the THF reflux temperature for 16 h and 
allowed us to dramatically improve the average yield of 2, 
ranging from 70 to 79%. 
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Scheme 2 Synthesis of rhodium(III) and ruthenium(II) complexes. 
 
Figure 1 Assignment of the methylene protons in the 1H NMR spectrum 5 
of 4: ABCD system, simulated (top) and experimental (bottom). 
The intermediate imidazolium salt 3a was prepared by reaction of 
2 with N-mesitylimidazole in the presence of NaI to facilitate the 
substitution (54% yield). This compound was characterised by 1H 
NMR to confirm the presence of the acidic proton, characteristic 10 
of an imidazolium salt, at 9.87 ppm. However, due to the 
potential hygroscopic nature of salts bearing halogen counter-
anions, and to the non-innocent behaviour of these anions in 
coordination chemistry, a metathesis with NaBF4 was carried out 
to afford 3b with an overall yield of 52% from 2. 1H NMR of 3b 15 
showed the characteristic imidazolium proton signal at 8.78 ppm, 
shifted upfield relative to 3a. 
 The NHC-thioether rhodium(III) and ruthenium(II) 
complexes 4 and 5 were then prepared by a one-pot synthesis in 
the presence of Ag2O as transmetallating agent.
6,17 The reaction 20 
was carried out with 3b in order to avoid a potential mixture of Cl 
and I on the Rh and Ru centres. It was conducted in the presence 
of excess Ag2O in dichloromethane at reflux. Forty hours were 
generally necessary to drive the reaction to completion and 
consume all the imidazolium salt, as confirmed by the 25 
disappearance of the proton signal at 8.78 ppm. The synthesis of 
silver carbene complexes from imidazolium salts containing non-
coordinating counteranions is known but usually requires harsher 
reaction conditions, such as high temperatures, longer reaction 
times and the use of molecular sieves, than those generated from 30 
halide-containing imidazolium salts.18 At least one example 
describes the use of such silver complexes in transmetallation 
reactions to prepare Rh(I) complexes.19 Cationic complexes 4 and 
5 were obtained in very good yields (4, 86%; 5, 85%) as deep red 
and orange solids respectively. Both complexes are air-stable and 35 
can be purified by column chromatography on neutral alumina. 
 
Characterisation of complexes 4 and 5 
The 1H and 13C NMR spectra of complex 4 confirmed the 
coordination of both NHC and thioether moieties. The 40 
coordination of the carbene on rhodium was evidenced by 13C 
NMR by a doublet at δ 166.3, with a coupling constant JRh-C of 54 
Hz, typical of rhodium(III)-NHC complexes.13-14,20 All three 
methyl groups from the mesityl moiety are now distinct, whereas 
the two ortho methyl groups had the same chemical shift in 3b. 45 
This means that the rotation of the mesityl group along the C-N 
bond is blocked, presumably because of close contact with the 
Cp* ligand. The CH2S signal shifts upfield on going from 3b (δ 
38.1) to 4 (δ 35.2). However, the effects of rhodium coordination 
were best evidenced by 1H NMR. All the protons of the 50 
SCH2CH2Im bridge become non equivalent and appear as a 
complex ABCD system composed of two doublets of doublets 
and two doublets of triplets, with the coupling pattern confirmed 
by a 2D-COSY 1H-1H experiment. This specific pattern is set by 
the conformational rigidity imposed by the presence of several 55 
bulky groups. Indeed, the measured coupling constants are in 
good agreement with those predicted from the measured dihedral 
angles from the X-ray structure of complex 4, allowing us to 
assign these resonances more precisely as shown in figure 1. As 
in the 13C NMR spectrum, differentiation of the two aromatic 60 
protons (slight) and ortho, ortho’ methyl substituents (large) is 
observed in the 1H NMR spectrum. 
 The 1H NMR spectrum of the ruthenium complex 5 showed a 
very different pattern, as all signals were broad even at low 
temperatures. The formation of the Ru-NHC bond, however, was 65 
confirmed by 13C NMR with a signal at δ 164.5, similar to other 
NHC ruthenium(II) complexes bearing a p-cymene substituent.6 
Most signals were assigned by 13C NMR: the o,o’-CH3 
substituents of the mesityl group were barely distinct, whereas 
both CH(CH3)2 signals from the p-cymene moiety were well 70 
separated at δ 20.4 and 24.8. The signals for the CH2Im carbon 
appeared in the expected region at δ 49.2, as well as the CH2S 
signal at δ 33.7. The 13C NMR signals for ferrocene were situated 
in the expected region between δ 72 and 68 but appeared very 
broad. The 1H NMR spectrum analysis was more complicated. 75 
The proton signals of the mesityl and p-cymene groups were 
assigned without ambiguity and all six methyl groups were 
differentiated. However, only one proton of CH2Im could be 
assigned at δ 4.86. The other one was not found even with the 
help of 2D 1H-1H or 1H-13C correlation experiments, as were the 80 
CH2S protons. Those might be overlapping with other signals, or 
broadened out. However, the mass spectrometry and X-ray 
diffraction analyses confirmed the expected structure for 5. 
 Complexes 4 and 5 were analysed by single crystal X-ray 
diffraction. Both structures consist of isolated cations and anions 85 
with no short interionic contacts. In compound 4, there is one 
CH2Cl2 solvent molecule. Comparison of selected bond distances, 
Sim.
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angles and torsion angles are given in Table 1 (also in Supporting 
Information) and ORTEP views for each complex are shown in 
Figure 2. The structures are closely related, they both contain the 
same thioether-NHC ligand chelating the metal to form a six-
membered ring and a Cl atom but differ by the -ligand: Cp* for 5 
the rhodium complex and p-cymene for the ruthenium compound. 
The Cp* is in 5-coordination mode whereas the p-cymene is in 
6-coordination. Considering these two ligands as a single  
 
 
Figure 2 Molecular views of compounds 4 (left) and 5 (right) with the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability 
level. H atoms have been omitted for clarity. 10 
 
Table 1 Selected bond lengths (Å), angles (°) and torsion angle (°) for 
complexes 4 and 5 
 4 (M = Rh) 5 (M = Ru) 
M1-Cg1 1.8334(8) 1.7460(15) 
M1-Cl1 2.3785(4) 2.3944(9) 
M1-S1 2.3622(4) 2.3501(10) 
M1-C5 2.0550(17) 2.091(4) 
S1-C2 1.822(2) 1.798(4) 
S1-C18 1.7631(9) 1.774(4) 
C2-C3 1.524(3) 1.510(6) 
C3-N4 1.459(2) 1.454(6) 
C7-C8 1.341(3) 1.331(7) 
   
Cg1-M1-Cl1 119.92(3) 125.09(6) 
Cg1-M1-S1 123.28(3) 119.72(6) 
Cg1-M1-C5 133.87(6) 134.56(12) 
Cl1-M1-S1 90.407(16) 91.66(4) 
Cl1-M1-C5 91.64(5) 81.79(11) 
S1-M1-C5 85.68(5) 91.54(12) 
   
S1-C2-C3-N4 -50.5(2) -73.3(4) 
Cg1 defines the centroid of the cycle above the metal. 
coordination site, the overall coordination geometry about each 15 
metal centre is pseudo-tetrahedral or typical piano-stool 
geometry. However, in the case of ruthenium p-cymene 
complexes, it is usual to describe them as pseudo-octahedral, the 
6-ligand occupying one face of the octahedron. The other three 
sites in complex 5 are occupied by the S1, C5 and Cl1 atoms. 20 
 Whatever the description of the coordination about the metal, 
the M1-S1, M1-C5 and M1-Cl1 bond lengths are comparable for 
the two compounds (Table 1). The only marked differences 
concern the angles. Indeed, the Cg1-M1-Cl1 angle is much larger 
for the ruthenium complex 5, 125.09(6)°, than for the rhodium 25 
one 4, 119.92(3)°. Such a difference may be explained by the 
bulkier p-cymene ligand with the substituted methyl roughly 
above the Cl position. Another difference is the larger value 
observed for the S1-Ru1-C5 angle – 91.54(12)° compared to 
85.68(5)° for S1-Rh1-C5. This is certainly related to the 30 
difference in conformation for the chelate ring, which is boat for 
the rhodium complex and half-chair for the ruthenium one. The 
difference is reflected in the S1-C2-C3-N4 torsion angles, -
50.5(2)° for 4 and -73.3(4)° for 5. This difference in 
conformation results in a different dihedral angle between the 35 
coordinated Cp of the ferrocene moiety and the imidazol-2-
ylidene ring: 61.03(12)° for 4 and 39.9(2°) for 5. 
 The Rh1-C5 distance of 2.0550(17) Å compares well with 
related NHC-Cp* rhodium complexes.20-21 The Ru1-C5 distance 
of 2.091(4) Å is slightly long but in the range of other NHC-40 
ruthenium complexes, which are found between 2.028(4) and 
2.0828(14) Å.6,21 The average M1-Cl1 and M1-S1 distances are 
in agreement with other structurally characterised cationic 5-Cp* 
rhodium or 6-p-cymene ruthenium complexes reported in the 
Cambridge Structural Database.22 Both ferrocene moieties have 45 
eclipsed conformation and usual geometry.22 
Electrochemistry 
The imidazolium salts 3a, 3b and complexes 4 and 5 were 
analysed by cyclic voltammetry in dichloromethane. The 
voltammogram of 3a exhibited several waves, as the iodide anion 50 
itself is redox-active.23 The redox potential for the ferrocene 
group is observed at E1/2 = +0.64 V/SCE with a chemically 
reversible behaviour (Ep is 120 mV, however, and may indicate 
slow electron transfer at the surface of the electrode). The 
voltammogram of 3b only shows the chemically reversible wave 55 
for the ferrocene unit at +0.64 V/SCE (Ep = 111 mV), see 
Figure 3.24 
 The FeII/FeIII couple in the rhodium complex 4 (Figure 4) is 
anodically shifted compared to the imidazolium salts with a 
potential of +0.77 V/SCE (Ep = 111 mV) and exhibits 60 
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chemically reversible behaviour. The anodic shift signals a weak 
electron-withdrawing effect of coordination to rhodium and 
indicates electronic communication between iron and rhodium 
through the sulfur atom. The cyclic voltammogram of the 
ruthenium complex 5 also presents a chemically reversible redox 5 
wave at +0.76 V/SCE (Ep = 84 mV) attributed to the Fe
II/FeIII 
couple, see Figure 4. A very weak oxidation wave was detected at 
approximately +1.7 V/SCE and was tentatively assigned to the 
RuII/RuIII couple. Analysis by square-wave voltammetry more 
clearly revealed this wave at +1.68 V/SCE (see Supporting 10 
Information), however it is far less intense than the FeII/FeIII 
wave. A similar Ru(II) p-cymene complex, bearing a chelating 
NHC-thioether ligand with methyl in place of ferrocenyl, exhibits 
a RuII/RuIII redox wave at +1.55 V/SCE.6 The anodic shift of the 
oxidation potential for the RuII/RuIII couple is attributed to the 15 
stronger electron-withdrawing effect of the oxidised form of 
ferrocene compared to CH3. The aspect of the voltammogram 
also suggests that the iron oxidation has an effect on the redox 
behaviour of ruthenium, whose oxidation becomes irreversible.25 
The electrochemical behaviour of both complexes suggests that it 20 
should be possible to alter selectively and reversibly the oxidation 




Figure 3 Cyclic voltammograms of imidazolium salts 3a (dashed) and 3b 
(plain), 1 mM in CH2Cl2 at a scan rate of 0.2 V/s.  
 
Figure 4 Cyclic voltammogram of complexes 4 and 5, 1 mM in CH2Cl2 at 
a scan rate of 0.2 V/s. 30 
Conclusions 
Two half-sandwich rhodium(III) and ruthenium(II) complexes 
bearing a new redox-active NHC-thioether ligand have been 
prepared and their electrochemical properties investigated. Cyclic 
voltammetry experiments have shown that the ferrocenyl unit can 35 
be oxidised and reduced reversibly. The catalytic properties of 
these complexes and the influence of the redox state of iron on 
the catalytic performances are under investigation and the results 
will be reported in due course. 
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Experimental 45 
General Procedures 
All reactions were performed under an atmosphere of dry 
nitrogen or argon using standard Schlenk techniques, unless 
otherwise stated. Solvents were dried and distilled by standard 
techniques prior to use. NMR spectra were recorded on Bruker 50 
AV300, AV400 or AV500 spectrometers. NMR chemical shifts 
were determined by reference to the residual 1H or 13C solvent 
peaks in the deuterated solvents. The NMR simulation 
experiment was done with SpinWorks 3. Electrospray (ES) mass 
spectra were recorded either at Imperial College on a Micromass 55 
LCT Premier spectrometer or at the Université Paul Sabatier by 
the Service Commun de Spectrométrie de Masse on a MS/MS 
API-365 (Perkin Elmer Sciex). Elemental analyses were 
performed either by Mr. Stephen Boyer at London Metropolitan 
University or by the Service d’Analyses du Laboratoire de 60 
Chimie de Coordination in Toulouse. Cyclic voltammetry (CV) 
and square-wave voltammetry (SQW) experiments were carried 
out with a PGSTAT-302N potentiostat (Metrohm) at 20°C using 
a Pt disk working electrode, a Pt wire counter electrode and a 
saturated calomel reference electrode (SCE); a 0.1 M n-Bu4BF4 65 
solution was used as the supporting electrolyte. All 
electrochemical data are referenced versus SCE. Bromoferrocene 
1 was prepared by a previously described procedure.26 
Syntheses 
2-Chloroethylthioferrocene (2).15-16 A solution of 70 
bromoferrocene (300 mg, 1.13 mmol, containing 92% FcBr, 7% 
ferrocene and 1% FcBr2) in THF (15 mL) was cooled to -78°C. n-
BuLi (800 L, 1.24 mmol) was added dropwise and the solution 
was stirred for 30 min at -78°C. A solution of 2-
chloroethyldisulfide (260 mg, 1.36 mmol) in THF (5 mL) was 75 
added dropwise and the mixture was allowed to warm to room 
temperature for 2 h. The mixture was then heated at 65°C for 16 
h. It was allowed to cool to room temperature and H2O (10 mL) 
was added. The phases were separated and the aqueous phase was 
extracted with Et2O. The organic phases were combined, washed 80 
with H2O, dried (MgSO4), filtered and concentrated in vacuo. The 
yellow liquid was purified by column chromatography on neutral 
alumina (grade I). The first band contained mainly ferrocene and 
the desired product was obtained as a yellow liquid in the second 
band (250 mg, 79%). 1H NMR (400 MHz, CDCl3)  4.34 (t, JHH 85 
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= 1.8 Hz, 2H, Cp), 4.26 (t, JHH = 1.8 Hz, 2H, Cp), 4.24 (s, 5H, 
Cp’), 3.60-3.56 (m, 2H, CH2Cl), 2.89-2.85 (m, 2H, CH2S). 
1-(-(ferrocenylthio)-ethyl)-3-(2,4,6-trimethylphenyl) 
imidazolium iodide (3a). A mixture of 2 (250 mg, 0.89 mmol), 
N-mesitylimidazole (249 mg, 1.34 mmol) and NaI (267 mg, 1.78 5 
mmol) in degassed acetonitrile (20 mL) was heated at 80°C for 
16 h. After cooling to room temperature, the solvent was 
evaporated and the residue taken up into CH2Cl2. The solution 
was filtered through Celite and the solvent evaporated to a 
minimum. Excess Et2O was added and the yellow precipitate was 10 
filtered on Celite, rinsed with Et2O then taken up into CH2Cl2. 
Evaporation of the solvent afforded 3a as a yellow solid (268 mg, 
54%). 1H NMR (400 MHz, CDCl3)  9.87 (t, JHH = 1.5 Hz, 1H, 
NCHN), 7.85 (t, JHH = 1.7 Hz, 1H, HC=CH Im
+), 7.20 (t, JHH = 
1.8 Hz, 1H, HC=CH Im+), 7.05 (s, 2H, CH Mes), 4.79 (pseudo t, 15 
JHH = 5.9 Hz, 2H, CH2Im
+), 4.34 (d, JHH = 1.8 Hz, 2H, Cp), 4.27 
(d, JHH = 1.8 Hz, 2H, Cp), 4.20 (s, 5H, Cp’), 3.21 (pseudo t, JHH = 
5.9 Hz, 2H, CH2S), 2.38 (s, 3H, p-CH3 Mes), 2.15 (s, 6H, o-CH3 
Mes). 
1-(-(ferrocenylthio)-ethyl)-3-(2,4,6-trimethylphenyl) 20 
imidazolium tetrafluoroborate (3b). Compound 2 (224 mg) was 
treated as described previously and crude 3a was dissolved in 
degassed CH2Cl2 (15 mL). A solution of NaBF4 (438 mg, 3.99 
mmol) in degassed H2O (10 mL) was added and the mixture was 
stirred vigorously for 16 h. The two phases were separated and 25 
the aqueous phase was extracted with CH2Cl2. The combined 
organic phases were washed with H2O, dried (Na2SO4), filtered 
and concentrated in vacuo to ca. 2 mL. Excess Et2O was added 
and the yellow precipitate was filtered through Celite, rinsed with 
Et2O then taken up into CH2Cl2. Evaporation of the solvent 30 
afforded 3b as a yellow solid (216 mg, 52%). 1H NMR (400 
MHz, CDCl3)  8.78 (s, 1H, NCHN), 7.73 (s, 1H, HC=CH Im
+), 
7.23 (s, 1H, HC=CH Im+), 7.03 (s, 2H, CH Mes), 4.48 (t, JHH = 
5.9 Hz, 2H, CH2Im
+), 4.33 (d, JHH = 1.7 Hz, 2H, Cp), 4.25 (d, JHH 
= 1.7 Hz, 2H, Cp), 4.18 (s, 5H, Cp’), 3.07 (t, JHH = 5.9 Hz, 2H, 35 
CH2S), 2.36 (s, 3H, p-CH3 Mes), 2.08 (s, 6H, o-CH3 Mes). 
13C 
NMR (100 Hz, CDCl3)  141.36 (Cquat Mes), 136.94 (NCHN), 
134.49 (2xCquat Mes), 130.64 (Cquat Mes), 129.83 (2xCH Mes), 
123.70 (C=C Im+), 123.52 (C=C Im+), 73.94 (2xCH Cp), 69.99 
(2xCH Cp), 69.61 (5xCH Cp’), 49.29 (CH2-Im
+), 38.07 (CH2S), 40 
21.14 (p-CH3 Mes), 17.32 (2x o-CH3 Mes). Cquat Cp not found. 
19F NMR (282 MHz, CDCl3)  -151.6 (BF4
-). MS (ESI+) m/z 431 
(M+, 100%). Elem. Anal. C24H27BF4FeN2S (518.03): calc. C, 
55.60; H, 5.25; N, 5.41; found C, 55.48; H, 5.28; N, 5.37. 
Rhodium complex (4). Imidazolium salt 3b (56.4 mg, 0.109 45 
mmol), [RhCp*Cl2]2 (59.3 mg, 0.096 mmol) and Ag2O (14.8 mg, 
0.064 mmol) were dissolved in dry CH2Cl2 (50 mL) and the 
Schlenk tube was protected from light. The mixture was heated at 
reflux for 40 h then filtered through Celite and the solvent was 
evaporated in vacuo. The residue was purified by column 50 
chromatography on neutral alumina (grade I, deactivated with 6-
8% H2O; eluent: CH2Cl2/MeOH 95:5) to give a deep red solid (74 
mg, 86%). X-Ray quality crystals were obtained by slow 
diffusion of cyclohexane in a saturated CH2Cl2 solution. 
1H NMR 
(400 MHz, CDCl3)  7.94 (d, 
3JHH = 1.8 Hz, 1H, HC=CH Im), 55 
6.83 (d, 3JHH = 1.8 Hz, 1H, HC=CH Im), 6.82-6.81 (m, 2H, 
C6H2(CH3)3), 5.33 (dd, 
2JHH = 14.6 Hz, 
3JHH = 3.0 Hz, 1H, 
CHCHDIm), 4.35 (app. s, 6H, 5xC5H5 + C5H4S), 4.26 (m, 1H, 
C5H4S), 4.20 (m, 1H, C5H4S), 3.91 (dd, 
2JHH = 14.2 Hz, 
3JHH = 
2.4 Hz, 1H, CHAHBS), 3.78 (td, 
2JHH = 
3JHH = 14.2 Hz, 
3JHH = 3.7 60 
Hz, 1H, CHCHDIm), 3.55 (td, 
2JHH = 
3JHH = 13.5 Hz, 
3JHH = 4.2 
Hz, 1H, CHAHBS), 3.34 (app. s, 1H, C5H4S), 2.29 (s, 3H, 
C6H2(CH3)3), 1.98 (s, 3H, C6H2(CH3)3), 1.76 (s, 3H, 
C6H2(CH3)3), 1.63 (s, 15H, C5(CH3)5). 
13C NMR (100 Hz, 
CDCl3)  166.29 (d, JCRh = 54.3 Hz, NCN), 139.10, 138.61, 65 
135.44, 133.57 (4x Cquat C6H2(CH3)3), 129.16, 127.32 (2xCH 
C6H2(CH3)3), 126.08, 124.75 (2x HC=CH Im), 100.03 (d, JCRh = 
6.2 Hz, (C5(CH3)5), 80.35 (Cquat C5H4S), 72.92 (CH C5H4S), 
70.21 (5xCH C5H5), 69.87, 69.02, 66.50 (3xCH C5H4S), 50.03 
(CH2Im), 35.17 (CH2S), 21.11, 20.08, 18.74 (3xC6H2(CH3)3), 70 
9.47 (C5(CH3)5). MS (ESI
+) m/z 703.5 (M+-BF4, 100%). Elem. 
Anal. C34H41BClF4FeN2RhS (790.50): calc. C, 51.61; H, 5.23; N, 
3.54; found C, 51.51; H, 5.16; N, 3.46. 
Ruthenium complex (5). Imidazolium salt 3b (52.0 mg, 0.1 
mmol), [Ru(p-cymene)Cl2]2 (54.0 mg, 0.088 mmol) and Ag2O 75 
(13.6 mg, 0.059 mmol) were dissolved in dry CH2Cl2 (30 mL) 
and the Schlenk tube was protected from light. The mixture was 
heated at reflux for 40 h then filtered through Celite and the 
solvent was evaporated to ca. 2 mL. Excess hexane was added 
and the precipitate was filtered through Celite, rinsed with hexane 80 
and recovered by dissolving in CH2Cl2. The solid was further 
purified by column chromatography on neutral alumina (grade I, 
deactivated with 6-8% H2O; eluent: CH2Cl2/MeOH 95:5) to give 
an orange solid (67 mg, 85%). X-Ray quality crystals were 
obtained by layering a saturated CDCl3 solution with methyl tert-85 
butyl ether. 1H NMR (500 MHz, CDCl3)  7.56 (br s, 1H, 
HC=CH Im), 7.20 (br s, 1H, C6H2(CH3)3), 7.09 (br s, 1H, 
C6H2(CH3)3), 6.84 (br s, 1H, HC=CH Im), 5.51, 5.07, 4.97 (br s, 
3x1H, CH p-cym), 4.87 (m, 1H, CH2Im), 4.70-4.30 (m, Xx1H, 
C5H4), 4.47 (br s, 5x1H, C5H5), 3.71 (br s, 1H, CH p-cym), 2.69 90 
(br s, 1H, (CH3)2CH p-cym), 2.44, 2.20, 1.98 (br s, 3x3H, 
C6H2(CH3)3), 1.81 (br s, 3H, CH3 p-cym), 1.23, 0.95 (br s, 2x3H, 
(CH3)2CH p-cym). 
13C NMR (125.8 MHz, CDCl3)  164.53 
(NCN), 141.02, 137.90, 137.45, 135.45 (4x Cquat C6H2(CH3)3), 
129.74, 129.67 (2xCH C6H2(CH3)3), 126.63, 122.67 (2x HC=CH 95 
Im), 107.77, 103.52 (2xCquat p-cym), 97.68, 93.16, 88.51, 79.78 
(4xCH p-cym), 71.08 (C5H5), 71.5-68.0 (C5H4), 49.20 (CH2Im), 
33.69 (CH2S), 29.51 ((CH3)2CH p-cym), 24.77 ((CH3)2CH p-
cym), 21.53 (C6H2(CH3)3), 20.41 ((CH3)2CH p-cym), 18.63, 
18.62 (C6H2(CH3)3), 17.95 (CH3 p-cym). MS (ESI
+) m/z 701 (M+-100 
BF4, 100%). 
X-ray crystallography. A single crystal of each compound was 
mounted under inert perfluoropolyether at the tip of a cryoloop 
and cooled in the cryostream of an Agilent Technologies OD  
XCALIBUR 3 CCD diffractometer for 4 or a GEMINI EOS CCD 105 
diffractometer for 5. Data were collected using the 
monochromatic MoK radiation (= 0.71073). The structures 
were solved by direct methods (SIR97) 27 and refined by least-
squares procedures on F2 using SHELXL-97.28 All H atoms 
attached to carbon were introduced in idealised positions and 110 
treated as riding on their parent atoms in the calculations. In 
compound 4, the BF4 was found to be disordered, and three 
orientations of ca. 81, 10 and 9% occupancy were identified. The 
geometries of all three orientations were optimised, the thermal 
parameters of adjacent equivalent atoms were restrained to be 115 
similar, and only the non-hydrogen atoms of the major occupancy 
orientation were refined anisotropically (the others were refined 
isotropically). The drawing of the molecules was realised with the 
help of ORTEP3.29 Crystal data and refinement parameters: see 
footntotes. Selected bond distances and angles are given in Table 120 
1. Crystallographic data (excluding structure factors) have been 
deposited with the Cambridge Crystallographic Data Centre as 
supplementary publication no. CCDC 816175-816176. Copies of 
the data can be obtained free of charge on application to the 
Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: 125 
(+44) 1223-336-033; e-mail: deposit@ccdc.cam.ac.uk). 
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